← Eichor
Study identifier: NCT06095440 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center

Condition: Hepatorenal Syndrome  ·  Sponsor: Methodist Health System

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Hepatorenal syndrome (HRS) is a common cause of acute kidney injury (AKI) in patients with liver disease \[1\]. Increased activity and presence of vasodilators such as nitric oxide in cirrhotic patients leads to vasodilation, especially in the splanchnic circulation, resulting in hemodynamic changes that precipitate renal injury \[1\]. Patients may present with elevated serum creatinine (Cr), benign urine sediment, and low urine sodium \[1\].

This description comes directly from the study's public registry record.

Talk to the study team

Colette Ngo Ndjom, MS  ·  214-947-1281  ·  MHSIRB@mhd.com

Loretta W Bedell, MPH  ·  214-947-4680  ·  mhsirb@mhd.com

Always discuss trial participation with your own doctor first.

Locations (1)

Liver Institute of Methodist Dallas Medical CenterDallas, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06095440